Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Spanish Registry of Cardioneuroablation (SRCNA)

11. november 2026 opdateret af: Teresa Barrio, Fundación de investigación HM

Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.

Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.

Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.

Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.

Study population

Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:

  • Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
  • Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
  • Functional sinus node dysfunction.
  • Functional AV block. Procedure

CNA is performed according to the usual practice of each center. The operator chooses:

  • the approach (right atrium, left atrium or both);
  • the number of GP targeted;
  • the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
  • the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
  • Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
  • Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
  • Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
  • Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.

Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.

Ongoing sub-studies:

  1. long-term follow-up of these patients and identification of predictors of recurrence;
  2. redo procedures, in patients requiring more than one CNA;
  3. patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.

Studieoversigt

Undersøgelsestype

Observationel

Tilmelding (Anslået)

400

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Albacete, Spanien
        • Rekruttering
        • Hospital Albacete
      • Alicante, Spanien
        • Rekruttering
        • Hospital General Alicante
        • Kontakt:
      • Badajoz, Spanien
        • Rekruttering
        • Hospital Badajoz
      • Barcelona, Spanien
      • Barcelona, Spanien
        • Rekruttering
        • Hospital Vall d´Hebron
      • Bilbao, Spanien
        • Rekruttering
        • Hospital de Basurto
        • Kontakt:
      • Córdoba, Spanien
        • Rekruttering
        • Hospital Reina Sofia
      • Girona, Spanien
        • Rekruttering
        • Hospital Josep Trueta
      • Granada, Spanien
        • Rekruttering
        • Hospital Virgen de las Nieves
      • Granada, Spanien
      • Huelva, Spanien
        • Rekruttering
        • Hospital Juan Ramón Jiménez
      • Madrid, Spanien
        • Rekruttering
        • Hospital Puerta de Hierro
        • Kontakt:
      • Madrid, Spanien
        • Rekruttering
        • Hospital 12 de Octubre
        • Kontakt:
          • Alvaro Marco, amarco89@hotmail.com
      • Madrid, Spanien
        • Rekruttering
        • Hospital Fundación Jiménez Díaz
      • Madrid, Spanien
        • Rekruttering
        • Hospital Gregorio Marañon
      • Madrid, Spanien
      • Madrid, Spanien
        • Rekruttering
        • Hospital Torrejon
        • Kontakt:
      • Navarro, Spanien
        • Rekruttering
        • Hospital Universitario de Navarra
        • Kontakt:
      • Santander, Spanien
        • Rekruttering
        • Hospital Valdecilla
      • Santiago de Compostela, Spanien
      • Valencia, Spanien
        • Rekruttering
        • Hospital La Fe
      • Valladolid, Spanien
        • Rekruttering
        • Hospital Valladolid
      • Vigo, Spanien
        • Rekruttering
        • Hospital Álvaro Cunqueiro
      • Vitoria-Gasteiz, Spanien
        • Rekruttering
        • Hospital Txagorritxu
      • Zaragoza, Spanien
        • Rekruttering
        • Hospital Miguel Servet
    • Madrid
      • Madrid, Madrid, Spanien, 28660
        • Rekruttering
        • Hospital HM Monteprincipe
        • Kontakt:
      • Madrid, Madrid, Spanien

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

patients treated with cardioneuroablation

Beskrivelse

Inclusion Criteria:

  • patients treated with cardioneuroablation

Exclusion Criteria:

-

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
syncope
Tidsramme: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)

recurrence of syncope

From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Complications
Tidsramme: During procedure and 3 months after

Complications

During procedure and 3 months after

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. juni 2018

Primær færdiggørelse (Anslået)

31. december 2030

Studieafslutning (Anslået)

31. december 2031

Datoer for studieregistrering

Først indsendt

6. november 2026

Først indsendt, der opfyldte QC-kriterier

11. november 2026

Først opslået (Faktiske)

17. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. november 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner